FDA · Life Science & Pharma: GxP - CSV & Data Integrity

FDA warning letter to Vi-Jon, LLC (2022)

Warning letter (closed) CSV & Data Integrity · Enforcement Last verified: not yet

Issued by
FDA
Category
CSV & Data Integrity
Sub Category
Enforcement
Legal weight
Warning letter: a flag, not a rule
Reuse
Public domain

An FDA warning letter to one firm, where deleted files were found on a computer and audit trails were not reviewed before batch release.

How to read this page

Details: Guide Definitions: every term and label explained

Lifecycle

Solid steps have happened. A dashed step is expected, and it is not a fact. Only dated steps in our record appear here.

  1. Done · 31 Mar 2022Warning letter issued
  2. Done · 8 Mar 2024Close-out letter issued

In plain English

An employee opened a computer recycle bin during the inspection and found deleted files, some with names like product formulas. The quality unit did not review HPLC audit trails before batch release.

Summary drafted with AI assistance. Not yet reviewed by the SME Reviewer. Read the official text before acting.

Context and history

FDA issued this warning letter to Vi-Jon, LLC on 31 Mar 2022. It concerns finished drugs, and it is listed here because of what it says about computerised systems or data integrity. FDA warning letters are public, and this one names the firm. It concerns one firm at one point in time, and it says nothing about the firm today or about other firms. FDA issued a close-out letter on 8 Mar 2024.

Who and what it applies to

This one firm. It is a record of enforcement, not guidance for everyone.

What it contains

Computer controls
FDA cited failure to control computer systems so that only authorised people make changes.
Deleted files
Deleted files and folders were found in a computer recycle bin.
Audit trail review
Audit trails were reviewed periodically, not before batch release.

Key points

  • Recycle bins are looked at during inspections.
  • Audit trail review before batch release was the issue here.
  • It binds one firm, and it shows how FDA applies existing rules.

In practice

General reading, not advice. This is drafted with AI and may not fit your situation. It does not replace the official text, your own quality system or qualified advice, and an inspector may take a different view.

  • Set when audit trails are reviewed relative to batch release.
  • Restrict deletion rights on laboratory computers.

Read from the source document on 2 Nov 2026. This is our own description, not the official text. Check the full dated history in the change log below.

Change log

Key dated events only, not a complete history. Status after is the status once that event happened. Event kinds explained

DateEventStatus afterSource
8 Mar 2024Close-out letter issuedWarning letter (closed)Source for Close-out letter issued
31 Mar 2022Warning letter issuedWarning letterSource for Warning letter issued

Official sources

The official text always prevails over anything on this site.

Source: FDA. Public domain.

Stay updated

Newsletter signup opens at launch.